These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20578712)

  • 21. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.
    Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets.
    Baurin N; Aboul-Ela F; Barril X; Davis B; Drysdale M; Dymock B; Finch H; Fromont C; Richardson C; Simmonite H; Hubbard RE
    J Chem Inf Comput Sci; 2004; 44(6):2157-66. PubMed ID: 15554686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ; Meegan MJ; Carta G; Lloyd DG
    J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noise reduction method for molecular interaction energy: application to in silico drug screening and in silico target protein screening.
    Fukunishi Y; Kubota S; Nakamura H
    J Chem Inf Model; 2006; 46(5):2071-84. PubMed ID: 16995738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient elimination of nonstoichiometric enzyme inhibitors from HTS hit lists.
    Habig M; Blechschmidt A; Dressler S; Hess B; Patel V; Billich A; Ostermeier C; Beer D; Klumpp M
    J Biomol Screen; 2009 Jul; 14(6):679-89. PubMed ID: 19470716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative assessment of scoring functions on a diverse test set.
    Cheng T; Li X; Li Y; Liu Z; Wang R
    J Chem Inf Model; 2009 Apr; 49(4):1079-93. PubMed ID: 19358517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
    Wabnitz PA; Loo JA
    Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New scoring functions for virtual screening from molecular dynamics simulations with a quantum-refined force-field (QRFF-MD). Application to cyclin-dependent kinase 2.
    Ferrara P; Curioni A; Vangrevelinghe E; Meyer T; Mordasini T; Andreoni W; Acklin P; Jacoby E
    J Chem Inf Model; 2006; 46(1):254-63. PubMed ID: 16426061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
    Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
    J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A screening library for peptide activated G-protein coupled receptors. 1. The test set.
    Lavrador K; Murphy B; Saunders J; Struthers S; Wang X; Williams J
    J Med Chem; 2004 Dec; 47(27):6864-74. PubMed ID: 15615535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
    Schlosser J; Rarey M
    J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
    Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
    Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
    Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
    J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for developing protein tyrosine phosphatase inhibitors.
    Tautz L; Mustelin T
    Methods; 2007 Jul; 42(3):250-60. PubMed ID: 17532512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico drug profiling of the human kinome based on a molecular marker for cross reactivity.
    Zhang X; Fernández A
    Mol Pharm; 2008; 5(5):728-38. PubMed ID: 18620417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying biologically active compound classes using phenotypic screening data and sampling statistics.
    Klekota J; Brauner E; Schreiber SL
    J Chem Inf Model; 2005; 45(6):1824-36. PubMed ID: 16309290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physics-based scoring of protein-ligand complexes: enrichment of known inhibitors in large-scale virtual screening.
    Huang N; Kalyanaraman C; Irwin JJ; Jacobson MP
    J Chem Inf Model; 2006; 46(1):243-53. PubMed ID: 16426060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.